TECX stock news · Tectonic Therapeutic, Inc.
Get alerts for TECX
Follow Tectonic Therapeutic, Inc. (TECX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TECXFree on the App Store and Google Play, or on the web.
Tectonic Therapeutic, Inc. will share its third quarter 2026 earnings report date, expecting no sales and a loss of $1.32 per share.
NeutralTectonic scheduled its third-quarter report for November 5, 2026. Analysts' $0 revenue and $1.32-per-share loss estimates are not company results, so the story does not change its outlook.
Tectonic Therapeutic, Inc. shares news about good results for its TX2100 treatment.
Good for TECXTectonic said it announced favorable early safety and drug-handling results for TX2100. This supports its treatment effort, though the filing gives no study details.